These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 29564578)
1. Acid sphingomyelinase activity as an indicator of the cell stress in HPV-positive and HPV-negative head and neck squamous cell carcinoma. Gerle M; Medina TP; Gülses A; Chu H; Naujokat H; Wiltfang J; Açil Y Med Oncol; 2018 Mar; 35(4):58. PubMed ID: 29564578 [TBL] [Abstract][Full Text] [Related]
2. Electrochemotherapy with cisplatin or bleomycin in head and neck squamous cell carcinoma: Improved effectiveness of cisplatin in HPV-positive tumors. Prevc A; Niksic Zakelj M; Kranjc S; Cemazar M; Scancar J; Kosjek T; Strojan P; Sersa G Bioelectrochemistry; 2018 Oct; 123():248-254. PubMed ID: 29898433 [TBL] [Abstract][Full Text] [Related]
3. Tyrosine Kinase Inhibition in HPV-related Squamous Cell Carcinoma Reveals Beneficial Expression of cKIT and Src. Kramer B; Kneissle M; Birk R; Rotter N; Aderhold C Anticancer Res; 2018 May; 38(5):2723-2731. PubMed ID: 29715092 [TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus predicts the outcome following concomitant chemoradiotherapy in patients with head and neck squamous cell carcinomas. Duray A; Descamps G; Decaestecker C; Sirtaine N; Gilles A; Khalifé M; Chantrain G; Depuydt CE; Delvenne P; Saussez S Oncol Rep; 2013 Jul; 30(1):371-6. PubMed ID: 23603900 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Rα/β expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro. Schultz JD; Mühlheim K; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A Oncol Rep; 2011 Nov; 26(5):1099-109. PubMed ID: 21805039 [TBL] [Abstract][Full Text] [Related]
6. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma. Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222 [TBL] [Abstract][Full Text] [Related]
7. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma. Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438 [TBL] [Abstract][Full Text] [Related]
8. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer. Spanos WC; Nowicki P; Lee DW; Hoover A; Hostager B; Gupta A; Anderson ME; Lee JH Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1137-46. PubMed ID: 19917928 [TBL] [Abstract][Full Text] [Related]
9. HPV-Related Head and Neck Squamous Cell Carcinomas. Marszałek A; Szylberg Ł Recent Results Cancer Res; 2017; 206():89-100. PubMed ID: 27699531 [TBL] [Abstract][Full Text] [Related]
10. [Relationship between human papilloma virus infection and expression of p16 and EGFR in head and neck squamous cell carcinoma and their prognostic significance]. Ma L; Wang D; Wufuer A; Wu R; Zhang S; Wang R Zhonghua Zhong Liu Za Zhi; 2014 Jan; 36(1):23-8. PubMed ID: 24685082 [TBL] [Abstract][Full Text] [Related]
11. The interplay between HPV and host immunity in head and neck squamous cell carcinoma. Andersen AS; Koldjaer Sølling AS; Ovesen T; Rusan M Int J Cancer; 2014 Jun; 134(12):2755-63. PubMed ID: 23913554 [TBL] [Abstract][Full Text] [Related]
12. HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice. Bishop JA; Lewis JS; Rocco JW; Faquin WC Semin Diagn Pathol; 2015 Sep; 32(5):344-51. PubMed ID: 25724476 [TBL] [Abstract][Full Text] [Related]
13. Experimental investigation of radiobiology in head and neck cancer cell lines as a function of HPV status, by MTT assay. Reid P; Wilson P; Li Y; Marcu LG; Staudacher AH; Brown MP; Bezak E Sci Rep; 2018 May; 8(1):7744. PubMed ID: 29773816 [TBL] [Abstract][Full Text] [Related]
14. Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines. Nagel R; Martens-de Kemp SR; Buijze M; Jacobs G; Braakhuis BJ; Brakenhoff RH Oral Oncol; 2013 Jun; 49(6):560-6. PubMed ID: 23578372 [TBL] [Abstract][Full Text] [Related]
15. Human Papillomavirus Status and the Risk of Cerebrovascular Events Following Radiation Therapy for Head and Neck Cancer. Addison D; Seidelmann SB; Janjua SA; Emami H; Staziaki PV; Hallett TR; Szilveszter B; Lu MT; Cambria RP; Hoffmann U; Chan AW; Wirth LJ; Neilan TG J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28855164 [TBL] [Abstract][Full Text] [Related]
16. Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives. Mirghani H; Amen F; Tao Y; Deutsch E; Levy A Cancer Treat Rev; 2015 Dec; 41(10):844-52. PubMed ID: 26476574 [TBL] [Abstract][Full Text] [Related]
17. HPV Integration in Head and Neck Squamous Cell Carcinomas: Cause and Consequence. Speel EJ Recent Results Cancer Res; 2017; 206():57-72. PubMed ID: 27699529 [TBL] [Abstract][Full Text] [Related]
18. [HPV-associated head and neck cancer: update and recommendations for practice]. Švajdler M; Laco J; Ondič O; Kašpírková J; Mezencev R; Michal M; Skálová A Cesk Patol; 2016; 52(3):130-8. PubMed ID: 27526013 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of HPV status in the re-irradiation of recurrent and second primary cancers of the head and neck. Velez MA; Wang PC; Hsu S; Chin R; Beron P; Abemayor E; St John M; Chen AM Am J Otolaryngol; 2018; 39(3):257-260. PubMed ID: 29433815 [TBL] [Abstract][Full Text] [Related]
20. Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells. Sørensen BS; Busk M; Olthof N; Speel EJ; Horsman MR; Alsner J; Overgaard J Radiother Oncol; 2013 Sep; 108(3):500-5. PubMed ID: 23953409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]